Cargando…
Emerging SARS-CoV-2 variants: Why, how, and what's next?
The emergence of the SARS-CoV-2 Omicron variant poses a striking threat to human society. More than 30 mutations in the Spike protein of the Omicron variant severely compromised the protective immunity elicited by either vaccination or prior infection. The persistent viral evolutionary trajectory ge...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057926/ https://www.ncbi.nlm.nih.gov/pubmed/37193049 http://dx.doi.org/10.1016/j.cellin.2022.100029 |
_version_ | 1784698009093668864 |
---|---|
author | Chen, Yu Liu, Qianyun Zhou, Li Zhou, You Yan, Huan Lan, Ke |
author_facet | Chen, Yu Liu, Qianyun Zhou, Li Zhou, You Yan, Huan Lan, Ke |
author_sort | Chen, Yu |
collection | PubMed |
description | The emergence of the SARS-CoV-2 Omicron variant poses a striking threat to human society. More than 30 mutations in the Spike protein of the Omicron variant severely compromised the protective immunity elicited by either vaccination or prior infection. The persistent viral evolutionary trajectory generates Omicron-associated lineages, such as BA.1 and BA.2. Moreover, the virus recombination upon Delta and Omicron co-infections has been reported lately, although the impact remains to be assessed. This minireview summarizes the characteristics, evolution and mutation control, and immune evasion mechanisms of SARS-CoV-2 variants, which will be helpful for the in-depth understanding of the SARS-CoV-2 variants and policy-making related to COVID-19 pandemic control. |
format | Online Article Text |
id | pubmed-9057926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90579262022-05-02 Emerging SARS-CoV-2 variants: Why, how, and what's next? Chen, Yu Liu, Qianyun Zhou, Li Zhou, You Yan, Huan Lan, Ke Cell Insight Review The emergence of the SARS-CoV-2 Omicron variant poses a striking threat to human society. More than 30 mutations in the Spike protein of the Omicron variant severely compromised the protective immunity elicited by either vaccination or prior infection. The persistent viral evolutionary trajectory generates Omicron-associated lineages, such as BA.1 and BA.2. Moreover, the virus recombination upon Delta and Omicron co-infections has been reported lately, although the impact remains to be assessed. This minireview summarizes the characteristics, evolution and mutation control, and immune evasion mechanisms of SARS-CoV-2 variants, which will be helpful for the in-depth understanding of the SARS-CoV-2 variants and policy-making related to COVID-19 pandemic control. Elsevier 2022-05-02 /pmc/articles/PMC9057926/ /pubmed/37193049 http://dx.doi.org/10.1016/j.cellin.2022.100029 Text en © 2022 Published by Elsevier B.V. on behalf of Wuhan University. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Chen, Yu Liu, Qianyun Zhou, Li Zhou, You Yan, Huan Lan, Ke Emerging SARS-CoV-2 variants: Why, how, and what's next? |
title | Emerging SARS-CoV-2 variants: Why, how, and what's next? |
title_full | Emerging SARS-CoV-2 variants: Why, how, and what's next? |
title_fullStr | Emerging SARS-CoV-2 variants: Why, how, and what's next? |
title_full_unstemmed | Emerging SARS-CoV-2 variants: Why, how, and what's next? |
title_short | Emerging SARS-CoV-2 variants: Why, how, and what's next? |
title_sort | emerging sars-cov-2 variants: why, how, and what's next? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057926/ https://www.ncbi.nlm.nih.gov/pubmed/37193049 http://dx.doi.org/10.1016/j.cellin.2022.100029 |
work_keys_str_mv | AT chenyu emergingsarscov2variantswhyhowandwhatsnext AT liuqianyun emergingsarscov2variantswhyhowandwhatsnext AT zhouli emergingsarscov2variantswhyhowandwhatsnext AT zhouyou emergingsarscov2variantswhyhowandwhatsnext AT yanhuan emergingsarscov2variantswhyhowandwhatsnext AT lanke emergingsarscov2variantswhyhowandwhatsnext |